Ala-geninthiocin

Ala-geninthiocin is a novel thiopeptide antibiotic derived from marine Streptomyces species (specifically, Streptomyces sp. ICN19). It belongs to the class of peptide-based natural products known as thiopeptides and has demonstrated potent in vitro antibacterial activity against Gram-positive bacteria, including Staphylococcus aureus, Bacillus subtilis, Mycobacterium smegmatis, and Micrococcus luteus. Additionally, it has shown cytotoxicity against A549 human lung carcinoma cells with an IC50 value of 6 nM. The compound was isolated through bioassay-guided fractionation and characterized by NMR and mass spectrometry techniques. Its mechanism of action is presumed to be similar to other thiopeptide antibiotics—likely involving inhibition of bacterial protein synthesis via interaction with the ribosome—but specific molecular targets for Ala-geninthiocin have not been definitively established[1][3][4].